Samsung Biologics signs record CMO deal with Pfizer
Samsung Biologics inked a $411 million contract manufacturing organization (CMO) letter of intent with Pfizer Ireland Pharmaceuticals, the biggest single deal the Korean company ever signed.
Samsung Biologics’ new production plant to be ready by April 2025
Samsung Biologics’ upcoming $1.5-billion production plant will be ready for operation by April 2025, five months earlier than previously expected, according to the pharmaceutical company Monday.
Samsung Biologics signs CMO agreement with U.S. company
Samsung Biologics inked a $112.5 million contract manufacturing organization (CMO) letter of intent with an unnamed U.S. biopharmaceutical firm, the Korean company said in a regulatory filing on Monday.
Samsung Biologics to go big on CDMO at BIO USA 2023
Samsung Biologics will be heavily promoting its capabilities in contract development and manufacturing organization (CDMO) at the BIO International Convention 2023 (BIO USA) in Boston, which is scheduled to begin on June 5.
Samsung chief looks to bio as new growth engine
Samsung Electronics Executive Chairman Lee Jae-yong had a round of meetings with global biopharmaceutical leaders to find a new growth engine beyond chips.
Samsung Biologics net profit falls 3.5 percent in first quarter
Samsung Biologics logged a weaker-than-expected profit in the first quarter, mainly due to an extraordinary item.
Lotte Biologics employee indicted for stealing trade secrets from Samsung
Prosecutors indicted a 39-year-old Lotte Biologics employee on Thursday on charges of stealing trade secrets from Samsung Biologics.
Samsung Biologics to build fifth plant in Songdo
Samsung Biologics will invest 1.98 trillion won ($1.51 billion) to build its fifth plant in Songdo, Incheon, further expanding its production capacity in contract manufacturing of biopharmaceutical products.
Samsung Biologics reports record profit and big earnings surprise
Samsung Biologics reported a 103 percent surge in net profit in 2022, with revenues and operating profit hitting records.
Samsung Biologics announces plans for four new factories
Samsung Biologics plans to build four new factories in a new manufacturing complex right next to its existing plants in Songdo, Incheon, committing 7.5 trillion won ($6 billion) into constructing the new cluster.